CD40 and neoplasm: Interestingly, despite T cell depletion, stable disease was still observed during treatment with ICIs, CD40 agonist and radiotherapy, suggesting that alternative mechanisms, such as activated myeloid cells, play a crucial role in maintaining tumor control [138].